- Report
- October 2025
- 93 Pages
Oman, Middle East
From €4162EUR$4,500USD£3,473GBP
- Report
- October 2025
- 91 Pages
Middle East
From €4162EUR$4,500USD£3,473GBP
- Report
- October 2025
- 90 Pages
Kuwait
From €4162EUR$4,500USD£3,473GBP
- Report
- October 2025
- 82 Pages
Qatar
From €4162EUR$4,500USD£3,473GBP
- Report
- October 2025
- 87 Pages
United States
From €4162EUR$4,500USD£3,473GBP
- Report
- October 2025
- 99 Pages
Philippines
From €4162EUR$4,500USD£3,473GBP
- Report
- October 2025
- 48 Pages
Global
From €1110EUR$1,200USD£926GBP
- Report
- October 2025
- 89 Pages
Middle East
From €4162EUR$4,500USD£3,473GBP
- Report
- October 2025
- 86 Pages
Middle East
From €4162EUR$4,500USD£3,473GBP
- Report
- October 2025
- 90 Pages
Saudi Arabia
From €4162EUR$4,500USD£3,473GBP
- Report
- August 2025
- 50 Pages
Global
From €9245EUR$9,995USD£7,715GBP
- Report
- July 2025
- 250 Pages
Global
From €2404EUR$2,599USD£2,006GBP
- Report
- June 2025
- 88 Pages
North America
From €3191EUR$3,450USD£2,663GBP
- Report
- June 2025
- 106 Pages
Global
From €3191EUR$3,450USD£2,663GBP
- Report
- June 2025
- 77 Pages
Japan
From €2266EUR$2,450USD£1,891GBP
- Report
- June 2025
- 194 Pages
Global
From €4578EUR$4,950USD£3,821GBP
- Report
- April 2025
- 59 Pages
Global
From €2729EUR$2,950USD£2,277GBP
- Report
- November 2024
- 82 Pages
Global
From €4625EUR$5,000USD£3,859GBP
- Report
- October 2024
- 83 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- September 2024
- 89 Pages
Global
From €4162EUR$4,500USD£3,473GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more